guanfacine BP
Selected indexed studies
- Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis. (Cardiovasc Res, 2024) [PMID:37890022]
- Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial. (Clin Auton Res, 2024) [PMID:39294522]
- Alpha-adrenergic receptors and blood pressure control. (Am J Cardiol, 1986) [PMID:2869681]
_Worker-drafted node — pending editorial review._
Connections
guanfacine BP is a side effect of
Sources
- Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial. (2024) pubmed
- Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis. (2024) pubmed
- Alpha-adrenergic receptors and blood pressure control. (1986) pubmed
- The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [(11)C]FLB457 PET Study. (2018) pubmed
- Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder. (2016) pubmed
- Pharmacokinetics and pharmacodynamics of guanfacine extended release in adolescents aged 13-17 years with attention-deficit/hyperactivity disorder. (2014) pubmed
- Guanfacine as monotherapy for systemic hypertension. (1986) pubmed
- Hypertension Update: Resistant Hypertension. (2018) pubmed
- An ambulatory trial of guanfacine. (1980) pubmed
- Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension. (1986) pubmed